- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Uremia alters HDL composition and cholesterol efflux capacity ; volume:13 ; number:1 ; day:17 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
BMC pharmacology & toxicology ; 13, Heft 1 (17.9.2012), 1, 9.2012
- Urheber
-
Holzer, Michael
- Beteiligte Personen und Organisationen
-
Birner-Grünberger, Ruth
Stojakovic, Tatjana
El-Gamal, Dalia
Binder, Veronika
Wadsack, Christian
Heinemann, Ákos
Marsche, Gunther
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-13-S1-A15
- URN
-
urn:nbn:de:1111-2016073153388
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Holzer, Michael
- Birner-Grünberger, Ruth
- Stojakovic, Tatjana
- El-Gamal, Dalia
- Binder, Veronika
- Wadsack, Christian
- Heinemann, Ákos
- Marsche, Gunther
- SpringerLink (Online service)
Ähnliche Objekte (12)
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Theobromine Does Not Affect Fasting and Postprandial HDL Cholesterol Efflux Capacity, While It Decreases Fasting miR‐92a Levels in Humans
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis